Belimumab in systemic lupus erythematosus
Systemic lupus erythematosus (SLE) is one of the most challenging autoimmune disorders with a complex pathophysiology and diverse clinical presentation. Many drugs have been used to treat SLE with suboptimal results, especially in patients with moderate-to-severe disease. Belimumab is the first biol...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
BMJ Publishing Group
2015
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612697/ |